Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carotid Artery IMT After Raloxifene Exposure
NCT00532246Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raloxifene in postmenopausal osteoporosis, sponsored by Eli Lilly and Company. Started Mar 2003; status: completed.
02
Drugs
raloxifene
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00532246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532246.